RD

Radhika Devi

Active Director Director DIN 08181065
DIN 08181065 First appointment Jul 2018 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2018
Shareholding value •••• Premium profile

About Radhika Devi

Data last updated:

Radhika Devi is a Director at Zenizen Pharmaceuticals Private Limited (since 2018). The company operates in Food And Beverages. Zenizen Pharmaceuticals Private Limited reported revenue of ₹50.8 Lakh (FY 2024).

DIN 08181065
Primary Designation Director
Industry Food And Beverages
First Appointment 17 Jul 2018
Oldest Company Age 8 yrs
Largest company Zenizen Pharmaceuticals Private Limited · ₹50.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jul 20182018₹50.8 Lakh (FY 2024)Active

Board colleagues of Radhika Devi

Directorship timeline

Open interactive timeline →
Zenizen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Radhika Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Radhika Devi

Radhika Devi currently holds 1 directorship: Zenizen Pharmaceuticals Private Limited (Director, since 17 Jul 2018, revenue ₹50.8 Lakh (FY 2024)).

Radhika Devi was first appointed on 17 Jul 2018 as Director at Zenizen Pharmaceuticals Private Limited.

The current boards of Radhika Devi's companies include Santosh Kumar Tiwary (Zenizen Pharmaceuticals Private Limited), Suresh Purty (Zenizen Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available